RADIANCE-HTN TRIO: key takeaways and implications for the treatment of hypertension - EuroPCR 2021

Ultrasound Renal Denervation with Dr. Sharp at EuroPCR 2021Подробнее

RADIANCE-HTN TRIO - Primary Analysis and ResultПодробнее

RADIANCE-HTN-TRIO: what does this mean for the treatment of hypertension? - EuroPCR 2021Подробнее

A review of the RADIANCE-HTN global clinical trial programme: a focus on the TRIO cohort - #EuroPCRПодробнее

Ultrasound Renal Denervation - Patient Perspective, Referral Development - Discussion @ EuroPCR 2021Подробнее

RADIANCE-HTN SOLO: primary outcomes of renal denervation - session webcastПодробнее

The Radiance HTN-SOLO results - A sound choice for Renal DenervationПодробнее

Redefining hypertension management with renal denervation - EuroPCR 2021Подробнее

How does Paradise renal denervation fit into hypertension treatment management? - EuroPCR 2021Подробнее

From proof to practice - Treating hypertension with ultrasound renal denervation - EuroPCR 2023Подробнее

Renal denervation for treatment of hypertension – heading for new shores - WebinarПодробнее

Ultrasound renal denervation: RADIANCE-HTN SOLO results - EuroPCR 2019Подробнее

RADIANCE signals a bright future for renal denervation - EuroPCR 2018Подробнее

ACC 2021 Discussion: The Randomized Sham-controlled RADIANCE-HTN TRIO TrialПодробнее

Crossover results from the RADIANCE-HTN SOLO trialПодробнее

TCT 2021: RADIANCE-HTN: 6Mo Outcomes of RDN Vs a Sham Procedure for Resistant HypertensionПодробнее

A Review of RADIANCE-HTN TRIO cohortПодробнее

Advancing the treatment of uncontrolled hypertension with ultrasound renal denervation - EuroPCR2022Подробнее

Renal Denervation for Hypertension: State of the Science in 2021Подробнее